Get Your Personalized Supplement StackSupplement Stack Quiz

Uva Ursi Glycerite Liquid Extract

Also known as: Uva Ursi, Bearberry, Arctostaphylos uva-ursi

Overview

Uva Ursi, scientifically known as *Arctostaphylos uva-ursi*, is an herbal extract derived from the leaves of the bearberry shrub. Traditionally, it has been utilized for its antiseptic and diuretic properties, primarily targeting urinary tract infections (UTIs) and associated symptoms. The key active compound is arbutin, which undergoes hydrolysis in the stomach to form hydroquinone, an antiseptic agent that is subsequently excreted in the urine. This glycerite liquid extract form is prepared by extracting the leaves in a glycerin-water solution, offering an alcohol-free alternative that preserves the plant's bioactive compounds. It is predominantly used for short-term symptomatic relief of UTIs and as a mild diuretic. While traditional use is extensive, research on its efficacy, particularly for glycerite liquid extracts, is moderate, with some clinical trials and in vitro studies supporting its antibacterial effects.

Benefits

Uva Ursi primarily offers antibacterial activity against common UTI pathogens like *Escherichia coli* and provides symptomatic relief for urinary tract discomfort. In vitro studies have demonstrated its ability to inhibit the growth of bacteria such as *Staphylococcus aureus* at concentrations achievable with extracts, suggesting a direct antimicrobial effect. A clinical study indicated that uva ursi extract reduced cystitis episodes over one year in women compared to placebo, showing promise for recurrent UTI management. The ongoing ATAFUTI study is further investigating its efficacy in reducing UTI symptoms and antibiotic use in women, with preliminary findings supporting its antibacterial potential. While large-scale randomized controlled trials are limited, existing evidence suggests it may offer symptom relief and potentially reduce the need for antibiotics in mild cases. It is typically used for short durations during acute UTI episodes due to safety considerations with prolonged use.

How it works

The primary mechanism of action for Uva Ursi involves the compound arbutin. Upon oral ingestion, arbutin is hydrolyzed in the stomach to hydroquinone, which is then absorbed into the bloodstream. Hydroquinone is subsequently excreted via the kidneys into the urine, where it exerts its antiseptic effects directly within the urinary tract by inhibiting bacterial growth. The extract also contains other beneficial compounds, such as tannins and flavonoids, which contribute to its overall antibacterial and anti-inflammatory properties. The glycerite extraction method specifically aims to preserve both water-soluble and glycerin-soluble bioactive compounds, ensuring their bioavailability and efficacy without the use of alcohol.

Side effects

Uva Ursi is generally considered safe for short-term use. The most commonly reported side effects are mild gastrointestinal upset and nausea. While potential hepatotoxicity has been a concern, significant liver injury has not been widely reported with controlled use. However, due to the release of hydroquinone, there are concerns regarding potential carcinogenicity with prolonged use, making long-term administration inadvisable. No major drug interactions have been definitively reported, but caution is advised when used concurrently with nephrotoxic medications. Uva Ursi is contraindicated in specific populations, including pregnant and breastfeeding women, and children, due to a lack of sufficient safety data in these groups. It is crucial to adhere to recommended short-term usage to mitigate potential risks.

Dosage

There is no universally standardized dosage for Uva Ursi glycerite liquid extract. However, traditional dosing for uva ursi leaf extracts typically ranges from 200-400 mg of arbutin daily. For safety, short courses, generally not exceeding 7 days, are strongly recommended to minimize potential risks associated with hydroquinone exposure. For glycerite extracts, dosage may need adjustment based on the specific concentration of the product, and general herbal tincture dosing guidelines often apply. It is usually advised to take Uva Ursi at the onset of acute UTI symptoms. For optimal absorption and efficacy, it is best taken with water, and it's important to avoid conditions that lead to alkaline urine, as this can reduce the release of the active antiseptic compound, hydroquinone.

FAQs

Is uva ursi glycerite extract effective for UTIs?

Evidence suggests antibacterial activity and symptom relief, but high-quality clinical trials specifically on the glycerite form are limited. It shows promise for mild cases.

Is it safe for long-term use?

No, due to potential toxicity from hydroquinone, only short-term use (up to 7 days) is advised to ensure safety and prevent adverse effects.

Can it replace antibiotics?

It may help reduce antibiotic need in mild, uncomplicated cases but should not be used as a substitute for antibiotics in severe or complicated infections.

Does glycerite form differ from alcohol tincture?

Yes, glycerite is alcohol-free, making it suitable for sensitive individuals. Its bioactivity appears preserved, offering a comparable alternative to alcohol-based tinctures.

Research Sources

https://journalejmp.com/index.php/EJMP/article/download/1264/2596/2346 – This in vitro study demonstrated that uva ursi extract effectively inhibited the growth of *Staphylococcus aureus* at low concentrations (MIC <200 µg/ml). The research indicates the extract's direct antibacterial potential, supporting its traditional use for infections, although further clinical correlation is needed.
https://pmc.ncbi.nlm.nih.gov/articles/PMC5591533/ – This source describes the protocol for the ATAFUTI trial, a planned randomized controlled trial investigating uva-ursi extract against ibuprofen and placebo for UTI symptom relief. The study aims to assess its role in reducing antibiotic use, highlighting a high-quality design for future clinical evidence.
https://www.ncbi.nlm.nih.gov/books/NBK556475/ – This clinical follow-up study involved 57 women with recurrent cystitis, showing that uva ursi treatment significantly reduced cystitis episodes over a year compared to placebo. The findings suggest a potential benefit for preventing recurrent UTIs, despite the study's small sample size.